-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core.PDF
January 01, 2010 - 10,596 0.14%
132: ATHEROSCLEROSIS W CC 19,069 0.24%
133: ATHEROSCLEROSIS W/O CC 2,027 0.03%
134: HYPERTENSION … cardiomyopathy (except that caused by
tuberculosis or sexually transmitted disease)
14,928 0.19%
98: Essential hypertension … 15,616 0.20%
99: Hypertension with complications and secondary hypertension 47,937 0.61%
100: Acute … 106,854 1.37%
182: Hemorrhage during pregnancy; abruptio placenta; placenta previa 10,068 0.13%
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core_Weighted.PDF
January 01, 2010 - 53,132 0.14%
132: ATHEROSCLEROSIS W CC 94,372 0.24%
133: ATHEROSCLEROSIS W/O CC 10,104 0.03%
134: HYPERTENSION … cardiomyopathy (except that caused by
tuberculosis or sexually transmitted disease)
75,082 0.19%
98: Essential hypertension … 78,926 0.20%
99: Hypertension with complications and secondary hypertension 240,804 0.62%
100: Acute … 533,506 1.37%
182: Hemorrhage during pregnancy; abruptio placenta; placenta previa 50,418 0.13%
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats.PDF
January 01, 2002 - /O CC 13878 0.18
132: ATHEROSCLEROSIS W CC 48037 0.61
133: ATHEROSCLEROSIS W/O CC 4556 0.06
134: HYPERTENSION … 15, 2005 38
Frequency Distribution for DXCCS1
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 14343 0.18
99: Hypertension with complications and secondary hypertension 49326 0.63
100: Acute myocardial … pregnancy 94348 1.20
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 11890 0.15
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2002 - DISORDERS W/O CC 1396 0.18
132: ATHEROSCLEROSIS W CC 4752 0.61
133: ATHEROSCLEROSIS W/O CC 478 0.06
134: HYPERTENSION … Distribution for DXCCS1 16:30 Monday, June 6, 2005
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 1416 0.18
99: Hypertension with complications and secondary hypertension 4988 0.64
100: Acute myocardial … pregnancy 9534 1.21
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 1196 0.15
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_B.PDF
January 01, 2002 - DISORDERS W/O CC 1401 0.18
132: ATHEROSCLEROSIS W CC 4743 0.60
133: ATHEROSCLEROSIS W/O CC 459 0.06
134: HYPERTENSION … Distribution for DXCCS1 16:32 Monday, June 6, 2005
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 1405 0.18
99: Hypertension with complications and secondary hypertension 4993 0.64
100: Acute myocardial … pregnancy 9365 1.19
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 1175 0.15
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_CORE.PDF
January 01, 2004 - /O CC 12585 0.16
132: ATHEROSCLEROSIS W CC 41256 0.52
133: ATHEROSCLEROSIS W/O CC 3731 0.05
134: HYPERTENSION … Distribution for DXCCS1 19:21 Thursday, August 17, 2006
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 15321 0.19
99: Hypertension with complications and secondary hypertension 46883 0.59
100: Acute myocardial … 106617 1.33
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 12742 0.16
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats.PDF
January 01, 2001 - /O CC 14028 0.19
132: ATHEROSCLEROSIS W CC 51100 0.69
133: ATHEROSCLEROSIS W/O CC 4383 0.06
134: HYPERTENSION … 15, 2005 38
Frequency Distribution for DXCCS1
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 12761 0.17
99: Hypertension with complications and secondary hypertension 48948 0.66
100: Acute myocardial … pregnancy 84390 1.13
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 10874 0.15
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2001 - DISORDERS W/O CC 1419 0.19
132: ATHEROSCLEROSIS W CC 5027 0.67
133: ATHEROSCLEROSIS W/O CC 420 0.06
134: HYPERTENSION … Distribution for DXCCS1 14:10 Thursday, June 9, 2005
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 1345 0.18
99: Hypertension with complications and secondary hypertension 4911 0.66
100: Acute myocardial … pregnancy 8445 1.13
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 1122 0.15
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats_10PCT_SAMPLE_B.PDF
January 01, 2001 - DISORDERS W/O CC 1469 0.20
132: ATHEROSCLEROSIS W CC 5142 0.69
133: ATHEROSCLEROSIS W/O CC 440 0.06
134: HYPERTENSION … Distribution for DXCCS1 14:17 Thursday, June 9, 2005
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 1230 0.17
99: Hypertension with complications and secondary hypertension 4894 0.66
100: Acute myocardial … pregnancy 8410 1.13
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 1056 0.14
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats.PDF
January 01, 2000 - /O CC 14381 0.19
132: ATHEROSCLEROSIS W CC 52228 0.70
133: ATHEROSCLEROSIS W/O CC 4869 0.07
134: HYPERTENSION … 15, 2005 38
Frequency Distribution for DXCCS1
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 12347 0.17
99: Hypertension with complications and secondary hypertension 50082 0.67
100: Acute myocardial … pregnancy 86552 1.16
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 11731 0.16
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2000 - DISORDERS W/O CC 1393 0.19
132: ATHEROSCLEROSIS W CC 5250 0.70
133: ATHEROSCLEROSIS W/O CC 488 0.07
134: HYPERTENSION … Distribution for DXCCS1 14:54 Thursday, June 9, 2005
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 1210 0.16
99: Hypertension with complications and secondary hypertension 4997 0.67
100: Acute myocardial … pregnancy 8636 1.16
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 1171 0.16
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats_10PCT_SAMPLE_B.PDF
January 01, 2000 - DISORDERS W/O CC 1459 0.20
132: ATHEROSCLEROSIS W CC 5251 0.70
133: ATHEROSCLEROSIS W/O CC 480 0.06
134: HYPERTENSION … Distribution for DXCCS1 14:52 Thursday, June 9, 2005
DXCCS1 Frequency
Percent
of
Total
98: Essential hypertension … 1203 0.16
99: Hypertension with complications and secondary hypertension 5116 0.69
100: Acute myocardial … pregnancy 8587 1.15
182: Hemorrhage during pregnancy, abruptio placenta, placenta previa 1183 0.16
183: Hypertension
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
January 01, 2009 - Frequency
Percent
of Total
132: ATHEROSCLEROSIS W CC 54 0.00%
133: ATHEROSCLEROSIS W/O CC 74 0.00%
134: HYPERTENSION … cardiomyopathy (except that caused by tuberculosis or sexually transmitted disease) 3,683 0.05%
98: Essential hypertension … 1,018 0.01%
99: Hypertension with complications and secondary hypertension 2,367 0.03%
100: Acute … 101,532 1.38%
182: Hemorrhage during pregnancy; abruptio placenta; placenta previa 5,438 0.07%
183: Hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
April 01, 2013 - When tested in adults with comorbid hypertension and depressive symptoms for whom previous
antimigraine … in reducing migraine days and migraine severity in patients with episodic migraine with or
without hypertension … migraine
medications specifically for patients with certain comorbidities (increased body mass index,
hypertension … When tested in adults with comorbid hypertension and depressive symptoms for whom previous
antimigraine … in reducing
migraine days and migraine severity in patients with episodic migraine with or without
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - data=MY_DATA_SET;
class patientid;
model biomarker_value =age female years statinA
statinB diabetes hypertension … patientid;
effect spl = spline(age);
model biomarker_value =spl female years statinA
statinB diabetes hypertension
-
www.ahrq.gov/sites/default/files/wysiwyg/topics/dxsafety-pediatric-safety.pdf
September 01, 2023 - In contrast, conditions commonly managed in the primary care setting (e.g., hypertension, depression, … interest in reducing diagnostic errors, especially for conditions that evolve over months
to years (e.g., hypertension … Project RedDE.13 Early retrospective work showed more than half of the opportunities to recognize
hypertension … provide actionable steps for other pediatric practices to address these three primary care issues
(hypertension
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
November 01, 2020 - for Hearing
Loss in Older Adults
Screening for Hepatitis B
in Adolescents & Adults
Screening for
Hypertension … in Adults
Screening for High Blood
Pressure in Children &
Adolescents
Screening for Lung Cancer … He is also co-director of the Hypertension Specialty
Clinic at Bellevue Hospital.
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
January 01, 2019 - MCC 4,806 0.10
302: ATHEROSCLEROSIS W MCC 1,503 0.03
303: ATHEROSCLEROSIS W/O MCC 6,704 0.14
304: HYPERTENSION … W MCC 9,439 0.20
305: HYPERTENSION W/O MCC 22,817 0.48
306: CARDIAC CONGENITAL & VALVULAR DISORDERS … MCC 4,805 0.10
302: ATHEROSCLEROSIS W MCC 1,506 0.03
303: ATHEROSCLEROSIS W/O MCC 6,704 0.14
304: HYPERTENSION … W MCC 9,446 0.20
305: HYPERTENSION W/O MCC 22,817 0.48
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Miller_93.pdf
March 12, 2008 - Evaluation of Medications Removed from Automated Dispensing Machines Using the Override Function Leading to Multiple System Changes
Evaluation of Medications Removed from Automated
Dispensing Machines Using the Override Function
Leading to Multiple System Changes
Karla Miller, PharmD; Manisha Shah, MBA, RT; Lau…
-
www.ahrq.gov/sites/default/files/2024-02/leapfrog-report.pdf
January 01, 2024 - Final Progress Report: The P4P Decision Tool: A Stakeholder Guide to Exploring and Selecting an Appropriate Pay-for-Performance Program
The P4P Decision Tool:
A Stakeholder Guide to Exploring and Selecting
an Appropriate Pay-for-Performance Program
Supported by a grant from the Agency for Healthcare Research and …